InsidersTradesSigma
Follow the Syncom Formulations (India) Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Syncom Formulations (India) Limited has logged 2 insider filings. Market capitalisation: €12.3bn. The latest transaction was disclosed on 16 June 2023 (Sale). Among the most active insiders: Shankarlal Bankda HUF. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Syncom Formulations (India) Limited 是一家从事药品生产的公司。该公司在印度的医疗保健和制药领域运营。